Beryl Drugs Ltd Holds 33rd AGM, Approves Financials and Director Re-appointment

Beryl Drugs Limited conducted its 33rd Annual General Meeting on September 29, 2026. The meeting, held in Indore, saw the adoption of the Audited Standalone Financial Statements for the Financial Year ended March 31, 2026. Shareholders also approved the re-appointment of Mr. Sudhir Sethi as a Director and authorized an increase in the limit for material related party transactions with m/s. Aminova Infusions Pvt. Ltd. The requisite quorum was present, and all resolutions were passed by ordinary resolution through e-voting and poll. The meeting concluded with a vote of thanks.